Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation

Pharmacotherapy

Volumn 20, Issue 10 I, 2000, Pages 1159-1166

  Patel, R J ^a   Witt, D M ^a   Saseen, J J ^a   Tillman, D J ^a   Wilkinson, D S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHYTOMENADIONE; PLACEBO; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; NORMAL VALUE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS;

EID: 0033775147     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.15.1159.34585     Document Type: Article

References (14)

1. Optimal oral anticoagulant therapy with mechanical heart valves
2. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
3. Correction of excessive anticoagulation with low-dose oral vitamin K
4. Low-dose oral Vitamin K reliably reverses over-anticoagulation due to warfarin
5. Retrospective and prospective analyses of the treatment of overanticoagulated patients
6. Evaluation of excessive anticoagulation in a group model health maintenance organization
7. Vitamin K to reverse excessive anticoagulation: A review of the literature
8. Management of anticoagulation before and after elective surgery
9. Clinical pharmacy anticoagulation services in a group model health maintenance organization
10. A method to determine the optimal intensity of oral anticoagulant therapy
11. Comparison of thromboplastins using the ISI and INR system
12. The international normalized ratio (INR) for monitoring warfarin therapy: Reliability and relation to other monitoring methods
13. Conservative treatment of overanticoagulation patients
14. Management of excessive oral anticoagulation without clinically evident bleeding